Non-coding DNA in IBD: from sequence variation in DNA regulatory elements to novel therapeutic potential

Area of Science:

• Genetics
• Immunology
• Molecular Biology

Background:

• Genome-wide association studies (GWAS) have identified over 200 loci linked to Inflammatory Bowel Disease (IBD).
• Recent research highlights that DNA regulatory elements (DREs) constitute the majority of IBD-associated loci, alongside protein-coding gene variants.
• This adds significant complexity to the genetic underpinnings of IBD.

Purpose of the Study:

• To review the current evidence on the role of DREs in IBD pathogenesis.
• To explore how epigenetic research can integrate non-coding variants into candidate gene studies.
• To identify critical pathways and cell types involved in IBD development.

Main Methods:

• Literature review of existing evidence on DREs and IBD.
• Discussion of epigenetic approaches for analyzing non-coding variants.
• Synthesis of findings to propose future research directions.

Main Results:

• The majority of IBD-associated loci are linked to DREs, significantly expanding the genetic landscape of the disease.
• Epigenetic research offers a framework to study non-coding variants and their role in IBD.
• DREs provide potential targets for novel therapeutic strategies.

Conclusions:

• DREs play a crucial role in the genetic susceptibility to IBD.
• Integrating epigenetic and genetic data is essential for understanding IBD pathogenesis.
• Targeting DREs, transcription factor binding, and enhancer activity presents promising avenues for IBD therapeutics.